• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在氟轻松醋酸酯(FAc)玻璃体内植入剂(Iluvien)注射器发生泄漏的情况下,注射该植入剂的替代技术。

Alternative technique for the injection of fluocinolone acetonide (FAc) intravitreal implant (Iluvien) in case of leakage of its injector.

作者信息

Diago Teresa, Fau Silvia G, Roca Jaime Moya

机构信息

Unit of Macula. Department of Ophthalmology, Hospital de La Ribera, Alzira, Valencia, Spain.

出版信息

Eur J Ophthalmol. 2023 May;33(3):1501-1505. doi: 10.1177/11206721221151136. Epub 2023 Jan 11.

DOI:10.1177/11206721221151136
PMID:36632008
Abstract

PURPOSE

To show an alternative surgical technique for the introduction of the intravitreal fluocinolone acetonide (FAc) implant (Iluvien) into the vitreous cavity using a 23-gauge (G) trocar if it is retained during its implantation in the subconjunctival space.

METHODS

We describe the surgical procedure performed to solve the complication: The FAc implant was extracted from the subconjunctival space using flat retinal forceps. A 23-G trocar was inserted 3,5 mm to the limbus. The same flat retinal forceps were used to take the FAc implant and introduce it into the vitreous cavity using a 23-G trocar.

RESULTS

The patient's best corrected visual acuity (BCVA) (Snellen) improved from 20/200 to 20/63 and the central macular thickness (CMT) was reduced from 610 microns (µm) to 215 µm after one week of the FAc implantation. He remained stable after 3 months of follow-up, with a BCVA of 20/63 and a CMT of 191 µm. His intraocular pressure (IOP) remained stable and the integrity of the implant was checked by indirect ophthalmoscopy.

CONCLUSION

The introduction of the intravitreal FAc implant using a 23-gauge trocar constitutes a valid alternative if it is retained during its implantation in the subconjunctival space.The functionality of the implant remained intact in our patient.

摘要

目的

展示一种替代手术技术,即在玻璃体内注射曲安奈德(FAc)植入物(Iluvien)植入结膜下间隙时若其滞留,如何使用23号(G)套管针将其引入玻璃体腔。

方法

我们描述了为解决该并发症所进行的手术步骤:使用扁平视网膜镊从结膜下间隙取出FAc植入物。在角膜缘3.5 mm处插入23G套管针。使用同一把扁平视网膜镊夹取FAc植入物,并通过23G套管针将其引入玻璃体腔。

结果

FAc植入一周后,患者的最佳矫正视力(BCVA)(Snellen)从20/200提高到20/63,中心黄斑厚度(CMT)从610微米(µm)降至215 µm。随访3个月后情况保持稳定,BCVA为20/63,CMT为191 µm。其眼压(IOP)保持稳定,通过间接检眼镜检查植入物的完整性。

结论

如果玻璃体内FAc植入物在植入结膜下间隙时滞留,使用23号套管针将其引入玻璃体腔是一种有效的替代方法。在我们的患者中,植入物的功能保持完好。

相似文献

1
Alternative technique for the injection of fluocinolone acetonide (FAc) intravitreal implant (Iluvien) in case of leakage of its injector.在氟轻松醋酸酯(FAc)玻璃体内植入剂(Iluvien)注射器发生泄漏的情况下,注射该植入剂的替代技术。
Eur J Ophthalmol. 2023 May;33(3):1501-1505. doi: 10.1177/11206721221151136. Epub 2023 Jan 11.
2
Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.《糖尿病黄斑水肿的 0.19mg 氟轻松玻璃体植入物三年的安全性和疗效:PALADIN 研究》。
Ophthalmology. 2022 Jun;129(6):605-613. doi: 10.1016/j.ophtha.2022.01.015. Epub 2022 Jan 19.
3
Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials.比较真实世界、非干预性 ICE-UK 研究和 FAME 随机对照试验中,氟轻松玻璃体植入物(ILUVIEN)治疗糖尿病性黄斑水肿患者的临床疗效数据。
Curr Med Res Opin. 2019 Jul;35(7):1165-1176. doi: 10.1080/03007995.2018.1560779. Epub 2019 Jan 17.
4
Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema.氟轻松醋酸酯 190µg 玻璃体腔内植入物治疗糖尿病黄斑水肿前后的视网膜厚度变化模式。
Curr Med Res Opin. 2017 Oct;33(sup2):33-43. doi: 10.1080/03007995.2017.1366662. Epub 2017 Sep 7.
5
Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study.玻璃体内细胞因子水平在单次 0.19mg 氟轻松醋酸酯(ILUVIEN®)植入物给药后在难治性糖尿病性黄斑水肿(DME)患者中的结果-来自 ILUVIT 研究。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2537-2547. doi: 10.1007/s00417-022-05564-2. Epub 2022 Mar 3.
6
Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.玻璃体内注射190μg醋酸氟轻松植入剂(ILUVIEN®)治疗慢性糖尿病性黄斑水肿:玻璃体切割术眼与未行玻璃体切割术眼的比较
Ophthalmic Res. 2018;59(2):68-75. doi: 10.1159/000484091. Epub 2017 Dec 16.
7
ILUVIEN in diabetic macular edema that persists or recurs despite treatment: Results from the Retina.pt RIVER audit.ILUVIEN 治疗后仍持续或复发的糖尿病性黄斑水肿:Retina.pt RIVER 审计的结果。
Eur J Ophthalmol. 2024 Jul;34(4):1149-1158. doi: 10.1177/11206721231217525. Epub 2023 Nov 28.
8
Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes.评估氟轻松醋酸酯 190µg 玻璃体腔内植入物治疗糖尿病性黄斑水肿的临床疗效:研究眼与对侧眼比较。
Curr Med Res Opin. 2017 Oct;33(sup2):19-31. doi: 10.1080/03007995.2017.1366659. Epub 2017 Sep 7.
9
The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema.氟轻松醋酸酯眼内植入物的疗效可通过糖尿病黄斑水肿对地塞米松植入物的反应来预测。
Eye (Lond). 2021 Dec;35(12):3232-3242. doi: 10.1038/s41433-020-01373-1. Epub 2021 Jan 21.
10
Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results.在阿联酋,氟轻松醋酸酯植入物治疗糖尿病性黄斑水肿患者的疗效和耐受性:12 个月的结果。
Eur J Ophthalmol. 2021 Nov;31(6):3196-3202. doi: 10.1177/1120672120982948. Epub 2021 Jan 10.

引用本文的文献

1
Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center.用于葡萄膜炎的曲安奈德植入剂:在三级中心剖析应答者和非应答者的结果
Biomedicines. 2024 May 16;12(5):1106. doi: 10.3390/biomedicines12051106.